EDAP will release Q3 2025 financial results on November 6, 2025, with a conference call at 8:30 AM EST.
Quiver AI Summary
EDAP TMS SA, a leader in robotic energy-based therapies, will announce its financial results for the third quarter of 2025 on November 6, 2025, before market opening. The announcement will be followed by a conference call and webcast at 8:30 AM EST, featuring key executives including the CEO, CFO, and Chief Accounting Officer. Interested parties can access the call through provided dial-in numbers or by registering for the webcast. EDAP specializes in developing minimally invasive medical devices using ultrasound technology, focusing on prostate cancer treatment with their Focal One® system. Additional information can be found on their website, and contact details for investor relations are also provided.
Potential Positives
- EDAP TMS SA is positioned as a leader in the emerging field of robotic energy-based therapies, indicating strong industry recognition and potential growth opportunities.
- The scheduled conference call and webcast with top executives demonstrates transparency and commitment to engaging with investors and stakeholders.
- The company’s focus on innovative technologies, such as the Focal One® system for prostate therapy, showcases its advancements in minimally invasive medical devices, which could enhance its market competitiveness.
Potential Negatives
- Announcement of upcoming financial results could indicate a lack of confidence about current operations if the prior performance was unsatisfactory.
- The timing of the conference call, scheduled for early morning, may suggest the company anticipates a challenging reception from investors or analysts.
- Details on product performance or advancements were not disclosed, which may raise concerns about the company's ongoing innovation and competitive standing.
FAQ
When will EDAP announce its third quarter 2025 financial results?
EDAP will announce its third quarter 2025 financial results on November 6, 2025, before market opening.
What time is the conference call for EDAP's Q3 2025 financial results?
The conference call is scheduled for November 6, 2025, at 8:30 am EST.
How can I participate in EDAP's earnings conference call?
You can participate by calling 1-800-274-8461 domestically or 1-203-518-9814 internationally.
What is the purpose of the conference call hosted by EDAP?
The conference call will provide insights into EDAP's third quarter financial performance and updates from company executives.
Where can I find more information about EDAP?
For more information about EDAP TMS SA, visit their official website at https://focalone.com/.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$EDAP Hedge Fund Activity
We have seen 8 institutional investors add shares of $EDAP stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANQUE TRANSATLANTIQUE SA removed 720,499 shares (-98.6%) from their portfolio in Q2 2025, for an estimated $1,188,823
- SCOGGIN MANAGEMENT LP removed 350,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $577,500
- APIS CAPITAL ADVISORS, LLC removed 297,712 shares (-56.8%) from their portfolio in Q2 2025, for an estimated $491,224
- ARCHON CAPITAL MANAGEMENT LLC removed 273,607 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $451,451
- UBS GROUP AG added 139,990 shares (+364.0%) to their portfolio in Q2 2025, for an estimated $230,983
- SUMMIT TRAIL ADVISORS, LLC added 102,339 shares (+inf%) to their portfolio in Q2 2025, for an estimated $168,859
- SAGE MOUNTAIN ADVISORS LLC added 100,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $165,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025
Company to host conference call and webcast on Thursday, November 6 th at 8:30am EST
AUSTIN, Texas, October 23, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the third quarter ended September 30, 2025, before the markets open on Thursday, November 6 th , 2025.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
Date: Thursday, November 6 th
Time: 8:30 am EST
Domestic: 1-800-274-8461
International: 1-203-518-9814
Passcode: EDAP
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1738018&tp_key=c91765d4a0
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One ® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
[email protected]
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
[email protected]
